Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis

被引:13
作者
Kaneko, Y
Yanagihara, K
Miyazaki, Y
Hirakata, Y
Mukae, H
Tomono, K
Okada, Y
Kadota, J
Kohno, S
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Grad Sch Med Sci, Dept Mol Microbiol & Immunol, Div Mol & Clin Microbiol, Nagasaki 852, Japan
[3] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Soja, Japan
关键词
mucin; MUC5AC; macrolide; diffuse panbronchiolitis; bronchoalveolar lavage;
D O I
10.1159/000074202
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The genetic identities of mucins secreted in the airways of patients with diffuse panbronchiolitis (DPB) have not been previously investigated, although hypersecretion is a common feature of this disease. Objective: The purpose of this study was to determine the production of MUC5AC, a major core protein of mucin in airway secretion, and the effect of macrolide treatment on such production in patients with DPB. Method: We performed Western blot analysis for MUC5AC of bronchoalveolar lavage fluid patients. Cases consisted of four groups including patients with DPB, idiopathic pulmonary fibrosis (IPF), and sarcoidosis, and healthy volunteers. Results: MUC5AC was detected in DPB patients but not in other groups. Macrolide treatment tended to inhibit such production in DPB patients. Conclusions: Our results suggest that overproduction of MUC5AC plays an important role in the pathogenesis of DPB. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 12 条
  • [1] BOAT TF, 1994, PHYSL BASES CONTROL, P217
  • [2] EPITHELIAL MUCIN GENES
    GENDLER, SJ
    SPICER, AP
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 : 607 - 634
  • [3] ERYTHROMYCIN INHIBITS RESPIRATORY GLYCOCONJUGATE SECRETION FROM HUMAN AIRWAYS INVITRO
    GOSWAMI, SK
    KIVITY, S
    MAROM, Z
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (01): : 72 - 78
  • [4] DIFFUSE PANBRONCHIOLITIS - A DISEASE OF THE TRANSITIONAL ZONE OF THE LUNG
    HOMMA, H
    YAMANAKA, A
    TANIMOTO, S
    TAMURA, M
    CHIJIMATSU, Y
    KIRA, S
    IZUMI, T
    [J]. CHEST, 1983, 83 (01) : 63 - 69
  • [5] A MECHANISM OF ERYTHROMYCIN TREATMENT IN PATIENTS WITH DIFFUSE PANBRONCHIOLITIS
    KADOTA, J
    SAKITO, O
    KOHNO, S
    SAWA, H
    MUKAE, H
    ODA, H
    KAWAKAMI, K
    FUKUSHIMA, K
    HIRATANI, K
    HARA, K
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01): : 153 - 159
  • [6] Keicho Naoto, 2002, Am J Respir Med, V1, P119
  • [7] Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin
    Kudoh, S
    Azuma, A
    Yamamoto, M
    Izumi, T
    Ando, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : 1829 - 1832
  • [8] INCREASE IN ACTIVATED CD8+ CELLS IN BRONCHOALVEOLAR LAVAGE FLUID IN PATIENTS WITH DIFFUSE PANBRONCHIOLITIS
    MUKAE, H
    KADOTA, J
    KOHNO, S
    KUSANO, S
    MORIKAWA, T
    MATSUKURA, S
    HARA, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) : 613 - 618
  • [9] Novel monoclonal antibody, SO-MU1, against human gastric MUC5AC apomucin
    Sotozono, M
    Okada, Y
    Sasagawa, T
    Nakatou, T
    Yoshida, A
    Yokoi, T
    Kubota, M
    Tsuji, T
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 192 (1-2) : 87 - 96
  • [10] Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: Inhibition by macrolides
    Tamaoki, J
    Takeyama, K
    Yamawaki, I
    Kondo, M
    Konno, K
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (01) : L15 - L19